Geode Capital Management
VTGN icon

Geode Capital Management’s VistaGen Therapeutics VTGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$546K Buy
272,907
+2,720
+1% +$5.44K ﹤0.01% 3528
2025
Q1
$676K Buy
270,187
+13,261
+5% +$33.2K ﹤0.01% 3435
2024
Q4
$758K Sell
256,926
-1,598
-0.6% -$4.72K ﹤0.01% 3462
2024
Q3
$778K Sell
258,524
-31,570
-11% -$95.1K ﹤0.01% 3441
2024
Q2
$1.01M Buy
290,094
+10,612
+4% +$36.9K ﹤0.01% 3302
2024
Q1
$1.48M Buy
279,482
+5,010
+2% +$26.5K ﹤0.01% 3228
2023
Q4
$1.41M Buy
274,472
+201,308
+275% +$1.04M ﹤0.01% 3214
2023
Q3
$384K Buy
73,164
+15,842
+28% +$83K ﹤0.01% 3701
2023
Q2
$107K Sell
57,322
-3,392,483
-98% -$6.34M ﹤0.01% 4309
2023
Q1
$430K Buy
3,449,805
+177,189
+5% +$22.1K ﹤0.01% 3700
2022
Q4
$337K Sell
3,272,616
-107,075
-3% -$11K ﹤0.01% 3843
2022
Q3
$514K Buy
3,379,691
+4,218
+0.1% +$641 ﹤0.01% 3709
2022
Q2
$2.97M Buy
3,375,473
+147,708
+5% +$130K ﹤0.01% 2970
2022
Q1
$4M Buy
3,227,765
+155,104
+5% +$192K ﹤0.01% 2930
2021
Q4
$5.99M Sell
3,072,661
-5,893
-0.2% -$11.5K ﹤0.01% 2794
2021
Q3
$8.44M Buy
3,078,554
+65,346
+2% +$179K ﹤0.01% 2587
2021
Q2
$9.49M Buy
3,013,208
+1,976,385
+191% +$6.23M ﹤0.01% 2493
2021
Q1
$2.21M Buy
1,036,823
+748,784
+260% +$1.59M ﹤0.01% 3212
2020
Q4
$558K Buy
288,039
+36,383
+14% +$70.5K ﹤0.01% 3555
2020
Q3
$175K Hold
251,656
﹤0.01% 3753
2020
Q2
$132K Hold
251,656
﹤0.01% 3786
2020
Q1
$110K Buy
251,656
+2,063
+0.8% +$902 ﹤0.01% 3735
2019
Q4
$172K Buy
249,593
+80,741
+48% +$55.6K ﹤0.01% 3844
2019
Q3
$180K Hold
168,852
﹤0.01% 3807
2019
Q2
$122K Buy
168,852
+14,395
+9% +$10.4K ﹤0.01% 3914
2019
Q1
$197K Hold
154,457
﹤0.01% 3749
2018
Q4
$231K Buy
154,457
+17,721
+13% +$26.5K ﹤0.01% 3628
2018
Q3
$198K Hold
136,736
﹤0.01% 3770
2018
Q2
$187K Buy
136,736
+106,639
+354% +$146K ﹤0.01% 3735
2018
Q1
$27K Hold
30,097
﹤0.01% 4001
2017
Q4
$33K Hold
30,097
﹤0.01% 3965
2017
Q3
$48K Hold
30,097
﹤0.01% 3942
2017
Q2
$56K Hold
30,097
﹤0.01% 3934
2017
Q1
$58K Hold
30,097
﹤0.01% 3925
2016
Q4
$112K Hold
30,097
﹤0.01% 3770
2016
Q3
$125K Buy
+30,097
New +$125K ﹤0.01% 3749